Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page version.SummaryDifference0.1%

- Check10 days agoChange DetectedNew entries show the latest study update date (2026-07-29) and the investigator listed with full credentials (Edward Kim, MD, PhD) along with recent context dates (2026-07-01, 2026-07). Older dates and the plain name Edward Kim were removed (2023-08-22, 2023-08-19, 2023-08), updating the study's authorship and revision history.SummaryDifference0.3%

- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a minor maintenance update that does not change the trial details presented.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedA new Revision: v3.6.3 tag has been added, replacing the previous v3.6.2 tag. This indicates a small update to the page’s content or formatting rather than substantive changes to the study details.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label was updated from v3.6.0 to v3.6.2, indicating a minor patch to the page's build. No study content or displayed information is changed.SummaryDifference0.1%

- Check60 days agoChange DetectedSeveral updates were made to the study record: new sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and a note about a revision (Revision: v3.6.0) appeared, while a formatting variation of the Intervention/Treatment label and an earlier revision note (Revision: v3.5.5) were removed or reformatted. The page now states that no participants are being recruited ('No longer looking for participants'), indicating the study is terminated and not enrolling new participants.SummaryDifference0.5%

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.